Literature DB >> 9103332

From the Centers for Disease Control and Prevention. Postmarketing surveillance for angiotensin-converting enzyme inhibitor use during the first trimester of pregnancy--United States, Canada, and Israel, 1987-1995.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9103332

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

Review 1.  Fortnightly review: drug treatment during pregnancy.

Authors:  P Rubin
Journal:  BMJ       Date:  1998-11-28

2.  Taking angiotensin-converting enzyme inhibitors during pregnancy: is it safe?

Authors:  Almundher Al-Maawali; Asnat Walfisch; Gideon Koren
Journal:  Can Fam Physician       Date:  2012-01       Impact factor: 3.275

3.  Prescription of antihypertensive medications during pregnancy in the UK.

Authors:  Lucia Cea Soriano; Brian T Bateman; Luis A García Rodríguez; Sonia Hernández-Díaz
Journal:  Pharmacoepidemiol Drug Saf       Date:  2014-05-02       Impact factor: 2.890

4.  The Fetal Safety of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers.

Authors:  Myla E Moretti; Daniela Caprara; Irina Drehuta; Emily Yeung; Stefanie Cheung; Lisa Federico; Gideon Koren
Journal:  Obstet Gynecol Int       Date:  2011-12-13

5.  7th Brazilian Guideline of Arterial Hypertension: Chapter 9 - Arterial Hypertension in pregnancy

Authors:  M V B Malachias; C E P Figueiredo; N Sass; I C Antonello; M R Torloni; M R F L Bortolotto
Journal:  Arq Bras Cardiol       Date:  2016-09       Impact factor: 2.000
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.